FDA expands labels for Roche's PATHWAY HER2 (4B5) test* and VENTANA HER2 Dual ISH DNA Probe Cocktail, which can now be used to identify HER2-positive metastatic breast cancer patients that could be ...
Verywell Health on MSN
The most effective HER2-positive breast cancer treatments
Medically reviewed by Marla Anderson, MD If you have HER2-positive breast cancer, your options for treatment will depend on ...
The Food and Drug Administration approved fam-trastuzumab deruxtecan-nxki, or Enhertu from Daiichi Sankyo (DSNKY), in combination with pertuzumab for the first-line treatment of adults with ...
In another first, Sandoz launched in November 2025 the first FDA-approved biosimilar of Tysabri (natalizumab). Tyruko (natalizumab-sztn) is used to treat adult patients with relapsing multiple ...
The highest rates of HER2 positivity were observed in bladder cancer, uterine serous carcinoma, and esophagogastric junction cancer. New research suggests the incidence of HER2 positivity is low ...
The FDA expanded the approval of trastuzumab deruxtecan (T-DXd, Enhertu) to include treatment of unresectable/metastatic hormone receptor (HR)-positive, HER2-low ...
Human epidermal growth factor receptor 2 (HER2)/neu overexpression, amplification and mutations are associated with an increased metastatic potential in cancer cells and poor prognosis. HER2 signaling ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results